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SYNOPSIS
In January 2015, during a 3-week period, 12 captive Tonkean 
macacques at a sanctuary in Italy died. An orthopoxvirus 
infection was suspected because of negative-staining elec-
tron microscopy results. The diagnosis was confirmed by 
histology, virus isolation, and molecular analysis performed 
on different organs from all animals. An epidemiologic in-
vestigation was unable to define the infection source in the 
surrounding area. Trapped rodents were negative by viro-
logic testing, but specific IgG was detected in 27.27% of 
small rodents and 14.28% of rats. An attenuated live vac-
cine was administered to the susceptible monkey popula-
tion, and no adverse reactions were observed; a detectable 
humoral immune response was induced in most of the vac-
cinated animals. We performed molecular characterization 
of the orthopoxvirus isolate by next-generation sequencing. 
According to the phylogenetic analysis of the 9 conserved 
genes, the virus could be part of a novel clade, lying be-
tween cowpox and ectromelia viruses.
Genus Orthopoxvirus virions are brick-shaped and rep-licate in the cytoplasm of eukaryotic cells (1). Some 
orthopoxviruses have limited host ranges; for example, 
ectromelia virus (ECTV) has only been described infect-
ing captive colonies of laboratory mice (2,3). Other ortho-
poxviruses can infect multiple animal species; for example, 
cowpox virus (CPXV) has been observed on multiple oc-
casions to spill over from its natural reservoir (presumably 
small wild rodents) to a wide variety of accidental hosts, 
including humans (4). The 3 orthopoxviruses raccoonpox, 
skunkpox, and volepox viruses are recognized as endemic 
in North America and are referred to as New World ortho-
poxviruses (5). The 6 orthopoxviruses variola virus, vac-
cinia virus (VACV), camelpox virus, monkeypox virus, 
ECTV, and CPXV are recognized as originating from the 
Eurasian continent and are referred to as Old World or-
thopoxviruses (6). Phylogenetic analyses have determined 
that CPXV is composed of multiple paraphyletic clades: 
VACV–like clade; variola virus–like clade; and CPXV 
clades 1, 2, and 3 (4,7). Moreover, analyses of 2 novel 
orthopoxviruses discovered in the country of Georgia (8) 
and the US state of Alaska (9) indicated they represented 
lineages distantly related from all previously known Old 
World and New World orthopoxviruses.
In Europe, western Russia, and northern and central 
Asia, CPXV is endemic, and in Europe, the numbers of re-
ports are increasing (10). Many studies have explored the 
variable pathogenic potential of CPXV, observing that vir-
ulence and the clinical manifestations of a given strain are 
often correlated with the affected host species (4). In par-
ticular, exotic animals from zoos and circuses are reported 
to be highly susceptible to CPXV infections (11–15).
Among nonhuman primates (NHPs), orthopoxvirus 
infections have been reported in New World monkeys 
(16), Barbary macaques (13), squirrel monkeys (17), 
and tamarins (14), but these infections have not been de-
scribed in the Tonkean macaque (Macaca tonkeana). The 
Tonkean macaque, belonging to the Cercopithecidae fam-
ily, is found in 4 protected areas in central Sulawesi (18); 
a few social groups live in 4 rescue centers in Europe, 
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SYNOPSIS
including in Italy, and in central America. Because of the 
limited number of these animals in sanctuaries, they are 
infrequently observed infected with orthopoxviruses, and 
thus, little information has been published regarding their 
disease signs and symptoms.
A few cases of orthopoxvirus infection have been re-
ported in Italy. In southern Italy, orthopoxvirus infections 
with CPXV have been described in domestic ruminants 
(19). At a farm in the region of Lazio, Italy, a CPXV out-
break occurred involving 7 llamas, which were suspected to 
have been infected via infected mice that were introduced to 
feed the birds of prey at the farm (20). Zoonotic infections 
caused by 2 almost identical orthopoxvirus isolates occurred 
in 2005 and 2007 in 2 veterinarians from northeastern Italy 
who acquired the infections during 2 separate incidents from 
2 different infected cats (21). Although definitive taxonomic 
assignment of these orthopoxviruses was not conclusive, 
hemagglutinin (HA) and crmB sequence analyses suggested 
possible segregation of these virus isolates from other previ-
ously described orthopoxvirus strains.
We describe a severe orthopoxvirus epidemic that oc-
curred in 2015 in a social group of Tonkean macaques host-
ed in a sanctuary for wild and exotic animals in a wooded 
area in central Italy, where 146 NHPs and 240 other wild 
and domestic mammals were maintained. To prevent other 
cases in NHPs, we undertook an immunization protocol and 
conducted epidemiologic investigations to detect orthopox-
virus carriers. We also performed taxonomic characteriza-
tion to determine its relatedness to other orthopoxviruses.
Methods
The colony of Tonkean macaques was introduced to the 
sanctuary in 2007 from the Strasbourg Primate Centre of 
Strasbourg University (Strasbourg, France); the original 
stock had been imported into France from Indonesia in 
1972. The colony hosted in the center at the time of the out-
break comprised 54 animals housed in 4 wide enclosures 
separated from each other at different distances.
In January 2015, twelve of the 18 Tonkean macaques 
housed in an enclosure located in the northern part of the 
natural reserve died within a 3-week period. The social 
group housed in the affected enclosure included both male 
and female animals, 1–20 years of age. Two macaques died 
within 48 hours after disease onset with severe respira-
tory syndrome. In the following weeks, 13 animals from 
the same enclosure displayed signs of depression, nausea, 
respiratory distress, and neurologic disease, and in several 
animals, skin and mucosa lesions developed (Figure 1). 
Ten of these 13 macaques died within 15 days after the 
appearance of signs and symptoms; 2 of 13 recovered af-
ter 6 and 8 days; and the remaining animal, an adult male, 
recovered but experienced long-lasting effects from the 
infection. This macaque had severe lesions limited to the 
right side of the face and the eye. In April, when this animal 
underwent surgery for eye ablation, oral and rectal swabs 
and a peripheral blood sample were acquired to detect virus 
and perform serologic studies.
The remaining 3 macaques in the same enclosure were 
constantly symptomless. Three days after the beginning of 
the outbreak, 2 of these macaques were immediately iso-
lated in a separate area, and the third, a 1-year-old, was left 
with the mother, which recovered from the illness. None 
of the other 9 NHP species, wild ruminants, wild boars, 
donkeys, raccoons, cats, or dogs hosted in the sanctuary 
showed any clinical signs related to orthopoxvirus infec-
tion in the following 12-month observation period.
At postmortem examination, major organs and skin le-
sions were collected from all dead Tonkean macaques and 
processed for routine histologic (hematoxylin and eosin) 
staining. Virus detection by negative-staining electron micros-
copy (EM) was conducted with skin lesion samples from 10 
animals (22). We extracted nucleic acid from homogenates of 
skin and lungs taken from 4 of the macaques and performed 
a molecular diagnostics investigation by using orthopoxvirus-
specific PCR assays. We performed an orthopoxvirus-specific 
SYBR Green (ThermoFisher Scientific, Waltham, MA, USA) 
real-time PCR targeting crmB (23), and to confirm the first 
result, we tested all samples with an additional endpoint PCR 
targeting the orthopoxvirus HA gene. We tested 1 tissue sam-
ple for the genes encoding acidophilic-type inclusion body 
(ATI) protein, chemokine-binding protein (K2R), 602-kDa 
protein, and 14-kDa fusion protein (A27L).
Using tissue homogenates of the skin and tongue mu-
cosa, brain, lungs, liver, spleen, heart, mesenteric lymph 
nodes, and intestines of the 12 dead animals (a total of 70 
samples), we conducted an additional SYBR Green real-
time PCR to confirm the presence of orthopoxvirus in all 
affected animals (Table 1). We performed virus culture by 
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Figure 1. Crater-shaped skin lesions at inguinal region of Tonkean 
macaque (Macaca tonkeana) housed at animal sanctuary, Italy, 
January 2015.
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taking tissue homogenates from up to 3 dead animals and 
inoculating them on Vero cells (CCL-81; American Tissue 
Culture Collection, Manassas, VA, USA). We sequenced 
the whole genome of the virus isolate by using the metage-
nomic approach with the Ion Torrent Personal Genome Ma-
chine platform for next general sequencing (ThermoFisher 
Scientific, Waltham, MA, USA). In brief, we grew the vi-
rus to passage 4 (titer 1 × 106.9 50% tissue culture infectious 
dose/mL) and concentrated it by ultracentrifugation. Then, 
we extracted pellet-associated DNA with E-Gel SizeSelect 
Agarose Gels (ThermoFisher Scientific) and quantified with 
Qubit dsDNA HS Assay Kit (ThermoFisher Scientific). We 
prepared DNA libraries with the Ion Xpress Plus gDNA 
Fragment Library Kit (ThermoFisher Scientific). We filtered 
sequence reads with the VirFind tool (http://virfind.org/j/) 
and de novo assembled sequences with Newbler version 
2.5.3 (454 Life Sciences, Branford, CT, USA). We aligned 
the 5 major contigs (length 13,743–108,913 nt) to CPXV-
Germany1998–2 (GenBank accession no. HQ420897.1) 
with MAUVE software (24) and concatenated the se-
quences. Inverted terminal repeats were excluded from the 
genome reconstruction.
We conducted epidemiologic investigations to ex-
amine virus transmission between working personnel and 
other animal species maintained in the reserve and to iden-
tify possible orthopoxvirus carriers (13). During February 
2015–April 2016, the following animals in the same sanc-
tuary died without specific symptoms: 9 NHPs, 2 foxes, 
and 1 cat. We conducted a virologic investigation for 
orthopoxvirus infection with the lungs, livers, spleens, and 
intestines of these dead animals.
After the outbreak, we initiated a 1-year rodent con-
trol program inside and in proximity to the enclosures. We 
captured 11 live mice (4 Apodemus flavicollis and 7 Mi-
crotus spp.) and 93 dead wild gray rats (Rattus rattus) by 
using multicapture live traps (Ugglan Special Mouse Trap 
2; Grahnab, Hillerstorp, Sweden) (25) and electromechani-
cal equipment. Lungs, liver, spleen, and small intestines of 
these animals were stored at –80°C until virologic analysis.
The sanctuary owner reported that 1 Japanese macaque 
(M. fuscata) had similar skin lesions (Figure 2) in 2003, and 
at that time, infection with a herpes zoster virus had been 
ruled out. This animal was still alive and was sampled for 
serologic investigations at the time of the 2015 outbreak.
We performed a serologic investigation with blood 
samples (stored at –20°C after collection) taken from 30 
various mammals (Table 2) and 62 NHPs (Table 3) housed 
at the sanctuary, as well as 11 mice and 56 dead rats. Detec-
tion of orthopoxvirus antibodies from NHPs and small ro-
dents was performed by indirect immunofluorescence anti-
body (IFA) assay with homemade slides that were seeded 
with Vero-E6 cells and infected with the smallpox vaccine 
virus Lancy-Vaxina (21). To detect orthopoxvirus-specific 
antibodies in other mammals, we used a virus neutraliza-
tion assay (20). We also conducted an epidemiologic and 
serologic investigation with the sanctuary staff (N = 11; 
group included veterinarians, researchers, and maintenance 
personnel) by performing a site visit and interviews and 
collecting blood samples.
Results
At necropsy, the 2 animals that died within 48 hours af-
ter symptom onset showed severe lung congestion (Figure 
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Table 1. Virologic examination of samples collected from 12 dead Tonkean macaques, Italy, January 2015* 
Method Skin Tongue mucosa Brain Lungs Liver Spleen Myocardium Lymph node Intestine Total 
Negative-staining EM 10/10 1/1 NA NA NA NA NA NA 0/12 11/23 
SYBR Green real-time PCR 10/10 1/1 3/3 12/12 10/12 12/12 3/3 5/5 3/12 59/70 
Cell culture 3/3 1/1 3/3 3/3 2/2 2/2 3/3 NA 0/3 17/20 
*Values are no. positive/no. total. EM, electron microscopy; NA, not analyzed. 
 
Figure 2. Crater-shaped skin lesions on face of Japanese 
macaque (Macaca fuscata), Italy, 2003.
 
Table 2. Serologic analysis of serum samples collected from 
various mammal species housed at animal sanctuary, Italy, 
January 2015 
Species 
Virus neutralization test, 
no. positive/no. total Antibody titer* 
Wolf 0/1 Negative 
Llama 0/8 Negative 
Roe deer 0/1 Negative 
Mouflon 0/1 Negative 
Goat 0/4 Negative 
Badger 0/1 Negative 
Donkey 0/2 Negative 
Cat 0/12 Negative 
Total 0/30  
*Threshold dilution was 1:4. 
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3, panel A) and hepatosplenomegaly. The 10 animals that 
died 5–15 days after onset of clinical signs had erythema-
tous papular and pustular lesions on the face, in the oral 
cavity, on the tongue mucosa (Figure 3, panel B), and at the 
inguinal region. All cutaneous lesions were characterized 
by focal epidermal necrosis and early vesiculation with 
eosinophilic intracytoplasmic inclusion bodies in enlarged 
degenerated cells (Figure 4, panel A). The liver showed 
scattered foci of necrosis and moderate steatosis. Foci of 
necrosis at the lymphoid follicles and histiocytosis associ-
ated with hemorrhages were observed in the spleen and at 
the lymph nodes. In some cases, mild interstitial pneumonia 
was associated with focal necrosis of bronchial epithelium.
Negative-staining EM revealed the presence of brick-
shaped particles morphologically consistent with ortho-
poxvirus in the skin lesions of 10 dead macaques (Figure 
4, panel B). Vero cell cultures inoculated with skin lesion 
materials from infected monkeys showed the previously 
described cytopathic effect (20) 3 days after inoculation. A 
viable transmissible agent, which we named orthopoxvirus 
Abatino, was consistently isolated and confirmed to be an 
orthopoxvirus by negative-staining EM.
Confirming the negative-staining EM results, SYBR 
Green real-time PCR detected an orthopoxvirus genome in 
all organs from the 12 dead macaques (Table 1); the melt-
ing temperature of the amplicons (80.8°C ± 1°C; Figure 4, 
panel C) was identical for all tested samples and consistent 
with that of orthopoxvirus genomes (23). The presence of 
the HA sequence in tissues confirmed infection with an or-
thopoxvirus and ruled out the presence of monkeypox.
Oral and rectal swabs collected 3 months after the epi-
demic from the recovered male macaque were negative by 
all virologic analyses. Retrospective examination of the 
sanctuary records of the past 2 years excluded the possibil-
ity of introduction of this orthopoxvirus through contacts 
with other mammal species maintained in captivity.
All tissue samples from the 104 small rodents trapped 
during February 2015–June 2016 were negative for ortho-
poxvirus by PCR. The animals that died in the sanctuary 
after the epidemic were negative for orthopoxvirus by all 
virologic tests performed.
The Japanese macaque that had orthopoxvirus-like 
skin lesions in 2003 showed an orthopoxvirus-specific IgG 
(but not IgM) titer of 1:80 by IFA assay. The IFA assay 
showed orthopoxvirus-specific IgG in 8 (14.28%) of 56 rats 
and in 3 (27.27%) Apodemus flavicollis mice of 11 small 
rodents (mice and voles). Orthopoxvirus-specific IgM was 
never detected (Table 4).
Among the NHPs outside of the affected enclosure, we 
detected orthopoxvirus IgG in 18 NHPs, 6 of which were 
asymptomatic Tonkean macaques maintained in an enclo-
sure near the affected one. Orthopoxvirus IgM was detected 
at low titer only in 2 Barbary macaques that never showed 
clinical signs of orthopoxvirus infection (Table 3).
Animal Vaccination
To prevent further infections, 96 NHPs of 8 species (M. 
tonkeana, M. fascicularis, M. sylvanus, M. fuscata, M. 
mulatta, Sapajus apella, Chlorocebus aethiops, and Papio 
hamadryas) were vaccinated during October–December 
1944 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 12, December 2017
 
Table 3. Serologic analysis of serum samples from nonhuman primate species housed at animal sanctuary, Italy, January 2015* 
Species 
IFA IgM test, no. 
positive/no. total (%) IgM titer† 
IFA IgG test, no. 
positive/no. total (%) IgG titer,† range 
Tonkean macaque (Macaca tonkeana) 0/30 Negative 8/30 1:401: 640 
Cynomolgus macaque (M. fascicularis) 0/11 Negative 3/11 1:201:160 
Barbary macaque (M. sylvanus) 2/12 1:20 2/12 1:20 
Rhesus macaque (M. mulatta) 0/1 Negative 1/1 1:80 
Japanese macaque (M. fuscata) 0/2 Negative 2/2 1:80 
Tufted capuchin (Sapajus apella) 0/4 Negative 2/4 1:20 
Grivet (Cercopithecus aethiops) 0/1 Negative 0/1 Negative 
Hamadryas baboon (Papio hamadryas) 0/1 Negative 0/1 Negative 
Total 2/62 (3.22)  18/62 (29.03)  
*IFA, immunofluorescence antibody. 
†Threshold dilution was 1:20. 
 
Figure 3. Results from necropsy 
of Tonkean macaque (Macaca 
tonkeana) from animal sanctuary, 
Italy, January 2015, showing 
severe congestion in the lungs 
(A) and erythematous papules 
and pustular lesions on the 
buccal and tongue mucosae (B).
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2015. Each animal received 2 doses of modified vaccinia 
virus Ankara (MVA) vaccine (Bavarian Nordic, Kvist-
gaard, Denmark) given 1 month apart, according to the 
producer’s immunization protocol. To assess possible vac-
cine-related adverse reactions, we monitored the NHPs for 
up to 10 days after dose administration and did not observe 
lesions at the vaccine inoculation site or general symptoms.
The immune responses to the vaccine were evaluated 
in a group of 10 animals (4 M. tonkeana, 5 M. fascicularis, 
and 1 M. sylvanus). Seven animals were negative for an-
tibodies before vaccination, and 3 had a barely detectable 
baseline IgG titer. After vaccination, all monkeys showed a 
2–5-fold increase of IgG titer. IgM were observed in the se-
rum of 4 animals at or near the minimum threshold dilution 
(1:20) on the day of vaccine booster administration (Table 
5). We did not detect viable virus or viral DNA shedding.
Molecular Characterization of Virus Isolate
After the positive results of the first diagnostic molecular 
analysis, we performed additional genus-specific PCRs tar-
geting HA, ATI, K2R, 602 kDa, and A27L with samples 
to better characterize the virus (26,27). We compared the 
complete nucleotide sequences of most amplicons with all 
orthopoxvirus full-genome sequences available in Gen-
Bank by using blastx+ version 2.2.28 (http://www.ncbi.
nlm.nih.gov/books/NBK279690). The HA gene sequence 
was closely related to that of CPXV-Germany_1998_2 
(GenBank accession no. HQ420897), with a 96% identity. 
K2R and 602-kDa protein gene sequences were closely 
related to those of ECTV-Moscow (GenBank accession 
no. AF012825), with a 96% identity for K2R (96% of 
gene sequence compared) and a 99% identity for 602-kDa 
protein. The A27L gene was closely related to those of 
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Figure 4. Results from 
necropsy of Tonkean macaque 
(Macaca tonkeana) from animal 
sanctuary, Italy, January 2015. 
A) Hematoxylin and eosin stain 
of cutaneous lesion. Focal 
epidermal necrosis, acanthosis 
ballooning degeneration, and 
acantholysis of keratinocytes 
were observed. Staining 
shows early vesiculation with 
eosinophilic intracytoplasmic 
inclusion bodies (arrows) in 
enlarged degenerated cells. 
Original magnificaton ×20. 
B) Electron micrograph of 
skin lesion sample showing 
negatively stained brick-shaped 
viral particle of ≈160–220 nm, 
consistent with orthopoxvirus. 
Scale bar = 100 nm. C) SYBR 
Green (ThermoFisher Scientific, 
Waltham, MA, USA) real-time 
PCR melting curve of all tested 
samples. The y-axis shows 
the ratio of the change in 
fluorescence over the change 
in temperature. The average 
melting temperature (80.8°C ± 
1°C) was consistent with that for 
the orthopoxvirus genome.
 
Table 4. Immunofluorescence antibody testing of serum samples from small wild rodents trapped at animal sanctuary, Italy,  
January 2015 
 IgM  IgG 
Species No. positive/no. total (%) Titer*  No. positive/no. total (%) Titer* 
Gray rat (Rattus rattus) 0/56 (0) Negative  1/56 1:20 
    4/56 1:40 
    3/56 1:80 
Total 0/56 (0)   8/56 (14.28)  
Voles (Microtus spp.) 0/7 Negative  0/7 Negative 
Yellow-necked mouse (Apodemus flavicollis) 0/4 Negative  3/4 1:40 
Total 0/11 (0)   3/11 (27.27)  
*Threshold dilution was 1:20. 
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ECTV-Naval and CPXV-Finland, with a 98% identity with 
both strains. Finally, the ATI gene sequence was most close-
ly related to that of the cowpox virus CPXV-Norway1994-
MAN (GenBank no. HQ420899.1), with a 98% identity.
Because of the discordant identity scores obtained 
with the preliminary molecular analyses, we sequenced the 
whole genome of the virus isolate by using next-generation 
sequencing. The sequence obtained was 202,990-nt long 
with a median coverage of 507 (range 28–817) nt. We iden-
tified 10 complete coding sequences and corrected inser-
tions and deletions manually.
The first coding sequence identified was the HA gene, 
which had a median coverage of 485 (range 255–586) nt 
(GenBank accession no. KY100116). We used this gene to 
check the sequence identity with PCR results and to compare 
the homology with all available orthopoxvirus strains. Ortho-
poxvirus Abatino shared 99% nucleotide identity and 98% 
amino acid identity with ECTV-Moscow and 96% nucleotide 
identity and 94% amino acid identity with CPXV-Germa-
ny1998–2. Furthermore, we observed that Abatino had HA 
identity scores of 97% for the nucleotide sequence and 96% 
for the amino acid sequence with FelinePoxITA1 (GenBank 
accession no. EF612709.1), an orthopoxvirus isolate previ-
ously obtained in 2007 from a zoonotic case in northeastern It-
aly that does not have a definitive taxonomic assignment (21).
Because phylogenetic relationships based on HA are 
not considered reliable for assigning orthopoxvirus taxo-
nomic relationships (7), we performed a more detailed 
analysis. Following a previously established pipeline 
(28,29), we performed core-genome selection, identity 
clustering, and phylogenetic reconstruction. Using blastx+, 
we identified the coding sequences of 9 conserved poxvirus 
genes (D1R, E6R, D5R, E9L, A7L, A10L, J6R, H4L, and 
A24R; VACV strain Copenhagen nomenclature; GenBank 
accession nos. KY100107–KY100115) uniformly distrib-
uted along the central region of the genome. The median 
coverage of the selected genes was 528 (range 80–743) nt. 
We aligned the concatenated sequences with homologous 
genes from available whole-sequence orthopoxvirus strains 
(4–7,9) by using MUSCLE version 3.8.31 (30).
The identity score matrix (Figure 5) identified the 11 
orthopoxvirus clusters described in previous reports (4,9). 
The identity score of orthopoxvirus Abatino with other or-
thopoxviruses ranged 93.26%–98.16%; the viruses with 
the highest identity scores to Abatino (98.14%, 98.15%, 
and 98.16%) were the 3 available ECTV sequences.
Using the Bayesian Markov chain Monte Carlo model 
(31) and the maximum-likelihood model (32), we per-
formed a phylogenetic analysis including a representative 
genome for each orthopoxvirus clade (Figure 6). The posi-
tion of orthopoxvirus Abatino was consistent with the re-
sults of the identity heat map.
Discussion
This epidemic indicated that Tonkean macaques are highly 
susceptible to infection with the isolated orthopoxvirus 
strain and might develop severe, fatal disease. Pathologic 
findings observed in dead animals were similar to those 
described in New World monkeys (16). Viable virus and 
viral DNA were detected not only in the cutaneous tissue 
and oral mucosa but also in many different organs, such as 
the liver and heart. Unfortunately, we could not detect vi-
able virus in the intestinal tissues, and therefore, we cannot 
hypothesize regarding the possibility of viral transmission 
through feces among living animals.
The severe disease was limited to a single Tonkean 
macaque social group, and the results of SYBR Green PCR 
suggested the involvement of the same viral agent, even if 
not all isolates were genetically characterized. The high IgG 
titers in 6 macaques from the neighboring enclosure, how-
ever, indicated they became infected during the outbreak. 
Orthopoxvirus IgM and IgG detected in some NHPs in other 
enclosures support the hypothesis that the virus circulated 
in the natural reserve, but no orthopoxvirus symptoms were 
observed in these animals, and no viral DNA or viable virus 
was isolated from them. Also, no other mammals hosted in 
the sanctuary appeared to have been exposed to the virus.
The illness observed years before in the Japanese ma-
caque that had orthopoxvirus-specific IgG suggests the pos-
sibility that an orthopoxvirus could have been circulating in 
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Table 5. Immunofluorescence antibody testing of vaccinated nonhuman primates after outbreak at animal sanctuary, Italy, January 
2015* 
Species No. animals IgM, T0/T30/T90 IgG, T0/T30/T90 No. (%) with IgG increase  
Tonkean macaque (Macaca tonkeana) 4 Neg/1:20/neg Neg/1:20/1:320 4 (100) 
  Neg/neg/neg Neg/1:20/1:80  
  Neg/neg/neg Neg/neg/1:80  
  Neg/neg/neg Neg/neg/1:40  
Cynomolgus macaque (M. fascicularis) 5 Neg/1:20/1:20 1:20/1:320/1:320 5 (100) 
  Neg/1:80/1:80 1:20/1:80/1:80  
  Neg/neg/neg Neg/1:20/1:80  
  Neg/1:20/1:20 Neg/1:20/1:80  
  Neg/neg/neg Neg/1:80/1:160  
Barbary macaque (M. sylvanus) 1 Neg/neg/neg 1:20/1:20/1:80 1 (100) 
*Threshold dilution for antibody titers was 1:20. Neg, negative; T0, first immunization; T30, booster dose administration; T90, blood collection 60 d  
after T30. 
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the area since at least 2003, although no evidence was avail-
able to indicate whether that remote episode was caused by 
the same virus strain identified in the 2015 outbreak. Sero-
logic evidence of orthopoxvirus infection in mice and rats 
confirms that mice and rats are susceptible to orthopoxvi-
ruses but does not definitively prove that they were infected 
with the virus responsible for the outbreak or establish their 
role as reservoirs, as has been described for rodents with 
other orthopoxvirus strains in previous studies (10,13).
The preliminary characterization of the isolated ortho-
poxvirus strain that was based on HA similarity analysis 
suggested that orthopoxvirus Abatino might be related to 
ECTV, CPXV clade 3, and a previous orthopoxvirus iso-
late that caused 2 zoonotic infections in northeastern Italy 
in 2005 and 2007 (21). On the other hand, the extended 
molecular characterization that was based on 9 conserved 
orthopoxvirus genes suggested that orthopoxvirus Abatino 
is in a distinct position with respect to all 11 orthopoxvi-
rus clades, being more related to ECTV than to all other 
orthopoxvirus clades. ECTV occasionally infects labora-
tory mice populations (2) and is suspected to naturally 
spread among wild rodents, although ECTV has never been 
isolated from these animals (3). Host range differences be-
tween all previously described ECTVs and orthopoxvirus 
Abatino strongly suggest that Abatino does not belong to the 
ECTV lineage. We hypothesize that orthopoxvirus Abatino 
might be part of a novel, paraphyletic ECTV-like clade. A 
recombination event that affected the host range could also 
be considered as a possible origin for this virus, but a more 
extensive characterization is necessary.
MVA vaccine follow-up showed a detectable humoral 
immune response. Data on the antibody classes elicited by 
live-modified VACV administration in humans and NHPs 
are scarce or unavailable (33). However, the observations 
of Silva-Fernandes et al. (34) describing outbreaks in hu-
mans together with our data in vaccinated monkeys sug-
gest that orthopoxvirus infections induce a limited IgM re-
sponse. On the other hand, the low antibody titers detected 
could have been caused by a poor sensitivity of the IFA test 
adopted. Finally, the MVA vaccine was safe in the monkey 
populations vaccinated; we observed no adverse reactions.
The serologic surveillance conducted among sanctuary 
staff workers showed 1 staff member who did not previously 
receive orthopoxvirus vaccine and had close contacts with the 
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Figure 5. Identity between OPV 
Abatino, obtained from skin lesion of 
Tonkean macaque during outbreak 
at animal sanctuary, Italy, January 
2015, and available OPV genomes 
on the basis of 9 concatenated 
conserved genes: A7L, A10L, A24R, 
D1R, D5R, H4L, E6R, E9L, and 
J6R. Red indicates more similarity, 
green less similarity. Sequences 
shown (GenBank accession 
nos.): 1) OPV Tena Dona AK2015 
(KX914668–76); 2) OPV GCP2013 
Akhmeta (KM046934–42); 4–6) 
ECTV-Moscow (AF012825.2), 
ECTV-Naval (KJ563295.1), ECTV-
VR-1431 (JQ410350.1); 7) VARV-
Bangladesh-1975 (L22579.1); 8–14) 
CPXV-HumLue09–1 (KC813494.1), 
CPXV-Germany1990–2 
(HQ420896.1), CPXV-Francy2001-
Nancy (HQ420894.1), CPXV-
MarLei07–1 (KC813499.1), CPXV-
Norway1994-MAN (HQ420899.1), 
CPXV-UK2000-K2984 
(HQ420900.1), CPXV-BrightonRed (AF482758.2); 15–16) MPXV-Congo2003–358 (DQ011154.1), MPXV-Liberia-1970–184 (DQ011156.1); 
17–18) VACV-IOC-B141 (KT184690.1), VACV-Lister (KX061501.1); 19–22) CPXV-Austria1999 (HQ407377.1), CPXV-HumLit08–1 
(KC813493.1), CPXV-GRI90 (X94355.2), CPXV-Finland2000 (HQ420893.1); 23) TATV-Dahomey-1968 (DQ437594.1); 24–25) CMLV-
0408151v (KP768318.1), CMLV-M96 (AF438165.1); 26‒31) CPXV-HumGra07–1 (KC813510.1), CPXV-RatKre08–2 (KC813505.1), CPXV-
RatGer09–1 (KC813503.1), CPXV-RatAac09–1 (KC813501.1), CPXV-HumAac09–1 (KC813508.1), CPXV-HumKre08–1 (KC813512.1); 
32) CPXV-Germany1998–2 (HQ420897.1); and 33–46) CPXV-Germany1980-EP4 (HQ420895.1), CPXV-HumPad07–1 (KC813496.1), 
CPXV-HumLan08–1 (KC813492.1), CPXV-RatHei09–1 (KC813504.1), CPXV-MonKre08–4 (KC813500.1), CPXV-JagKre08–1 
(KC813497.1), CPXV-JagKre08–2 (KC813498.1), CPXV-Germany2002-MKY (HQ420898.1), CPXV-HumGri07–1 (KC813511.1), CPXV-
HumMag07–1 (KC813495.1), CPXV-CatBer07–1 (KC813502.1), CPXV-HumBer07–1 (KC813509.1), CPXV-CatPox07–1 (KC813506.1), 
CPXV-BeaBer04–1 (KC813491.1). CMLV, camelpox virus; CPXV, cowpox virus; ECTV, ectromelia virus; MPXV, monkeypox virus; OPV, 
orthopoxvirus; TATV, taterapox virus; VACV, vaccinia virus; VARV, variola virus.
SYNOPSIS
affected Tonkean macaque group seroconverted without clin-
ical signs, suggestive of an asymptomatic infection. However, 
alternative explanations for this seroconversion (e.g., previ-
ous exposure to a closely related virus) could not be ruled out.
This study might be considered alarming because ortho-
poxvirus vaccination has been discontinued globally since 
the late 1970s, which has resulted in the reduction of pro-
tective immunity over time not only against smallpox virus 
but also against a variety of other orthopoxviruses, raising 
the chances of orthopoxvirus infections occurring in humans. 
Orthopoxvirus infection in humans is not a notifiable disease 
in Italy, and because virologic diagnosis relies on specialized 
laboratories, orthopoxvirus infection is often not included 
among the differential diagnosis. Increased public awareness 
and linkage between human and veterinary health authorities 
is necessary to improve public health measures for the con-
trol of zoonotic orthopoxviruses.
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Figure 6. Phylogenetic analysis of 
OPV Abatino obtained from skin 
lesion of Tonkean macaque during 
outbreak at animal sanctuary, Italy, 
January 2015. Nine conserved 
genes (GenBank accession nos. 
KY100107–KY100115) obtained 
with next-generation sequencing 
were concatenated and aligned 
with the homologous concatenated 
sequences from representative 
OPV strains (GenBank accession 
no.): TATV-Dahomey-1968 
(DQ437594.1), VARV-
Bangladesh-1975 (L22579.1), 
CMLV-M96 (AF438165.1), CPXV-
HumAac09–1 (KC813508.1), 
CPXV-Germany2002-MKY 
(HQ420898.1), CPXV-
Germany1998–2 (HQ420897.1), 
CPXV-MarLei07–1 (KC813499.1), 
MPXV-Congo2003–358 
(DQ011154.1), CPXV-Finland2000 
(HQ420893.1), VACV-Lister 
(KX061501.1), ECTV-Moscow 
(AF012825.2), OPV GCP2013 
Akhmeta (KM046934–42), 
and OPV Tena Dona AK2015 
(KX914668–76). New World 
strain RACV-MD19 (GenBank 
accession no. FJ807746–54) was added to the analysis as an outgroup. We generated multiple alignments with MUSCLE version 3.8.31 
(30) and built the phylogenetic tree by using the Bayesian Markov chain Monte Carlo model with MRBAYES version 3.2.5 (31) using the 
general time-reversible plus gamma model with 1 million generations, retaining a minimum of 10,000 posterior probabilities, and maximum-
likelihood model RAxML version 8.1.24 (32) using the general time-reversible plus gamma with 1,000 pseudoreplicates. Numbers represent 
the reliability of the nodes with the minimum probability of 75% and minimum bootstrap value of 75. Scale bar indicates nucleotide 
substitutions per site. CMLV, camelpox virus; CPXV, cowpox virus; ECTV, ectromelia virus; MPXV, monkeypox virus; OPV, orthopoxvirus; 
RACV, raccoonpox virus; TATV, taterapox virus; VACV, vaccinia virus; VARV, variola virus.
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